Quinacrine, a drug once used to treat malaria, has found to have a positive effect in treating mesothelioma. The drug researchers — who came from Penn State, Texas Tech, Keck Graduate Institute in California and St. John’s University— found that when mesothelioma cells were treated with quinacrine, they stopped migrating and forming new colonies that eventually become tumors.
The team of researchers reported overall positive findings from the application of quinacrine to mesothelioma, with natural cell death, prevention of the growth of tumor-feeding blood vessels showing the most promise.
The article was published in The International Journal of Molecular Science. Read it here.
If you or a loved one has been diagnosed with mesothelioma as a result of exposure to asbestos, contact the experienced attorneys at Nass Cancelliere. For more than 35 years, the Philadelphia-based law firm of NASS CANCELLIERE has represented 4,000 people who have contracted MESOTHELIOMA and other forms of asbestos-related illness. Our attorneys have tried over 1,000 cases throughout Pennsylvania and New Jersey and we have collected over $500 million for our clients. Learn more by calling 215-546-8200 to speak with an attorney.